tiprankstipranks
Trending News
More News >
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
NASDAQ:KNSA
US Market

Kiniksa Pharmaceuticals (KNSA) Revenue

Compare
543 Followers

Kiniksa Pharmaceuticals Revenue

Kiniksa Pharmaceuticals had a revenue of 180.85M in the quarter ending Sep 30, 2025, with 15.34%. This bring the company's revenue in the last twelve months to 597.97M, Decreased 12.97%. In the fiscal year ending Dec 31, 2024, Kiniksa Pharmaceuticals had annual revenue of 423.24M with 56.60% growth.
Revenue (ttm)
597.97M
Revenue Growth
55.68%
P/S Ratio
7.61
Revenue/Employee
$1,343,616
Employees
315
Market Cap
$3.22B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
423.24M152.98M+156.60%
Dec 31, 2023
270.26M50.08M+122.74%
Dec 31, 2022
220.18M181.64M+571.24%
Dec 31, 2021
38.54M-3,854,400,000.00%
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016